SciELO - Scientific Electronic Library Online

 
vol.42 número2Frecuencia de ansiedad y depresión en pacientes hospitalizados en el Hospital de Clínicas “Dr. Manuel Quíntela”, Montevideo, Uruguay índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Revista Médica del Uruguay

versión impresa ISSN 0303-3295versión On-line ISSN 1688-0390

Resumen

KSIAZENICKI, Mariana et al. Respiratory follow-up of patients with COVID-19 pneumonia after hospital discharge: experience at a uruguayan centre. Rev. Méd. Urug. [online]. 2026, vol.42, n.2, e201.  Epub 27-Abr-2026. ISSN 0303-3295.  https://doi.org/10.29193/rmu.42.2.6.

Introduction:

Viral pneumonitis is the main cause of hospital admission in patients with COVID-19. Timely post-discharge follow-up should be performed to diagnose and manage the main respiratory complications.

Objective:

To describe the clinical, radiological, and functional follow-up after hospital discharge for COVID-19 pneumonitis.

Materials and methods:

Observational, analytical, retrospective study. Hospitalised patients from January to July 2021 with a discharge diagnosis of COVID-19 pneumonitis were included. Follow-up was conducted both by telephone and in person, including clinical, imaging, and spirometric assessment in those with dyspnoea and/or abnormal imaging at 8 weeks after discharge.

Results:

n=590 patients, 355 men. Age: 52±14 (mean±SD) years. Comorbidities: hypertension (34%), obesity (18%), chronic respiratory diseases (17%), diabetes (16%), smoking (12%). Admission to the intensive care unit n=73 (12%); high-flow oxygen therapy n=52 (9%), non-invasive mechanical ventilation n=19 (3%), and invasive mechanical ventilation n=14 (2%). Eleven percent developed severe disease. Obesity/overweight was significantly associated with severe disease (OR 2.33; 95% CI 1.32–4.10; p=0.004). Severe disease was associated with a higher likelihood of discharge with home oxygen (OR 2.05; 95% CI 1.19–3.53; p=0.008). Twenty-three percent required oxygen therapy at discharge. Corticosteroid therapy for more than 10 days: n=119 (20%). At 4–8 weeks, 62% had persistent symptoms, with dyspnoea being the most frequent (24%). At 4–12 weeks, 31% showed persistent radiological abnormalities. Eighteen percent (n=33) of spirometry tests performed were abnormal, with a predominance of a restrictive pattern (28/33).

Conclusions:

A significant proportion of patients hospitalised for COVID-19 pneumonia presented clinical, radiological, and functional respiratory sequelae during post-discharge follow-up. Initial severity and obesity/overweight were associated with worse outcomes. These results support the implementation of structured respiratory follow-up programmes in this population.

Palabras clave : SARS-CoV-2; Hospitalisation; Follow-up; COVID-19; Complications.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )